Clinical improvement of myasthenia gravis by treatment with a chimeric anti-CD4 monoclonal antibody.
Ahlberg
R
R
Department of Medicine, Karolinska Hospital, Stockholm, Sweden.
Yi
Q
Q
Pirskanen
R
R
Matell
G
G
Swerup
C
C
Rieber
P
P
Riethmüller
G
G
Holm
G
G
Lefvert
A K
AK
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D015704:CD4 Antigens / Q000276:immunology; D005260:Female; D006801:Humans; D007167:Immunotherapy; D016131:Lymphocyte Subsets / Q000276:immunology; D008875:Middle Aged; D009157:Myasthenia Gravis / Q000628:therapy*; D011993:Recombinant Fusion Proteins
D000911:Antibodies, Monoclonal; D015704:CD4 Antigens; D011993:Recombinant Fusion Proteins